PROFUND ADVISORS LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in TGTX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$2,526,015

+$295,810 QoQ

Shares Held

76,039

+1.6% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. TGTX ranks #7 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc. This page	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,526,015	76,039	+1.6%	Shares	Sole	2026-04-27
2025-12-31	$2,230,205	74,814	+48.9%	Shares	Sole	2026-02-06
2025-09-30	$1,815,100	50,245	+13.1%	Shares	Sole	2025-11-06
2025-06-30	$1,599,467	44,442	+4.9%	Shares	Sole	2025-08-07
2025-03-31	$1,671,240	42,385	-37.7%	Shares	Sole	2025-05-08
2024-12-31	$2,047,492	68,023	-5.1%	Shares	Sole	2025-02-14
2024-09-30	$1,675,682	71,641	+14.4%	Shares	Sole	2024-11-14
2024-06-30	$1,113,938	62,616	-27.0%	Shares	Sole	2024-08-13
2024-03-31	$1,304,957	85,796	-8.2%	Shares	Sole	2024-05-08
2023-12-31	$1,596,792	93,489	-34.9%	Shares	Sole	2024-02-14
2023-09-30	$1,200,337	143,581	+154.4%	Shares	Sole	2023-11-13
2023-06-30	$1,402,168	56,448	-37.6%	Shares	Sole	2023-08-10
2023-03-31	$1,359,676	90,404	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.